{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:59:38Z","timestamp":1772121578126,"version":"3.50.1"},"reference-count":30,"publisher":"VM Media Group sp. z o.o","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.rpor.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T10:45:51Z","timestamp":1598093151000},"page":"876-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimodality treatment in malignant pleural mesothelioma \u2013 Ordeal or real deal?"],"prefix":"10.5603","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6083-9225","authenticated-orcid":false,"given":"Naveen","family":"Mummudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asfiya","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Tibdewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabita","family":"Jiwnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Karimundackal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.S.","family":"Pramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Prakash","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"issue":"August (9483)","key":"10.1016\/j.rpor.2020.08.006_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet Lond Engl"},{"issue":"August (Suppl 21)","key":"10.1016\/j.rpor.2020.08.006_bib0010","doi-asserted-by":"crossref","first-page":"S2565","DOI":"10.21037\/jtd.2018.07.65","article-title":"Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma","volume":"10","author":"Cramer","year":"2018","journal-title":"J Thorac Dis"},{"issue":"May","key":"10.1016\/j.rpor.2020.08.006_bib0015","first-page":"63","article-title":"Modern management of malignant pleural mesothelioma","volume":"7","author":"Patel","year":"2016","journal-title":"Lung Cancer Targets Ther"},{"issue":"December (6)","key":"10.1016\/j.rpor.2020.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","article-title":"Trimodality therapy for malignant pleural mesothelioma: Results from an EORTC phase II multicentre trial","volume":"36","author":"Van Schil","year":"2010","journal-title":"Eur Respir J"},{"issue":"October (29)","key":"10.1016\/j.rpor.2020.08.006_bib0025","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2017.73.8401","article-title":"Long-term survival outcomes of cancer-directed surgery for malignant pleural mesothelioma: Propensity score matching analysis","volume":"35","author":"Nelson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"August (8)","key":"10.1016\/j.rpor.2020.08.006_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: Clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.rpor.2020.08.006_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MCP.0000000000000489","article-title":"Updates in the diagnosis and treatment of malignant pleural mesothelioma","volume":"24","author":"Katzman","year":"2018","journal-title":"Curr Opin Pulm Med"},{"issue":"16","key":"10.1016\/j.rpor.2020.08.006_bib0040","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): A randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.rpor.2020.08.006_bib0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5761\/atcs.oa.10.01572","article-title":"Improving survival results after surgical management of malignant pleural mesothelioma: An Australian institution experience","volume":"17","author":"Yan","year":"2011","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"February (2)","key":"10.1016\/j.rpor.2020.08.006_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1258\/jrsm.2010.100345","article-title":"A systematic review of lung-sparing extirpative surgery for pleural mesothelioma","volume":"104","author":"Teh","year":"2011","journal-title":"J R Soc Med"},{"issue":"February (2)","key":"10.1016\/j.rpor.2020.08.006_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer Amst Neth"},{"issue":"12","key":"10.1016\/j.rpor.2020.08.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: A surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"issue":"March (3)","key":"10.1016\/j.rpor.2020.08.006_bib0065","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"November (5)","key":"10.1016\/j.rpor.2020.08.006_bib0070","article-title":"Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"84","author":"Rice","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"February (2)","key":"10.1016\/j.rpor.2020.08.006_bib0075","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2017.09.036","article-title":"National trends in the epidemiology of malignant pleural mesothelioma: A national Cancer data base study","volume":"105","author":"Saddoughi","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rpor.2020.08.006_bib0080","doi-asserted-by":"crossref","unstructured":"Mahmoudi. Evaluation of the photon dose calculation accuracy in radiation therapy of malignant pleural mesothelioma [Internet]. [cited 2020 April 30]. Available from: http:\/\/www.cancerjournal.net\/article.asp?issn=0973-1482;year=2018;volume=14;issue=5;spage=1029;epage=1035;aulast=Mahmoudi.","DOI":"10.4103\/0973-1482.187284"},{"issue":"July (3)","key":"10.1016\/j.rpor.2020.08.006_bib0085","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"December (5)","key":"10.1016\/j.rpor.2020.08.006_bib0090","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ijrobp.2007.07.2370","article-title":"Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy","volume":"69","author":"Krayenbuehl","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"November (11)","key":"10.1016\/j.rpor.2020.08.006_bib0095","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/JTO.0b013e3181b9eb85","article-title":"Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: A dosimetric comparison of two well-described techniques","volume":"4","author":"Hill-Kayser","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"February (2)","key":"10.1016\/j.rpor.2020.08.006_bib0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"March (2)","key":"10.1016\/j.rpor.2020.08.006_bib0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jrr\/rru102","article-title":"Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy","volume":"56","author":"Kimura","year":"2015","journal-title":"J Radiat Res (Tokyo)"},{"issue":"9","key":"10.1016\/j.rpor.2020.08.006_bib0110","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"de","year":"2017","journal-title":"Lancet Oncol"},{"issue":"August (8)","key":"10.1016\/j.rpor.2020.08.006_bib0115","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(16)30095-X","article-title":"Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): A multicentre, open-label, phase 3, randomised controlled trial","volume":"17","author":"Clive","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpor.2020.08.006_bib0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2019.05.024","article-title":"Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17\/04 trial","volume":"138","author":"Riesterer","year":"2019","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"23","key":"10.1016\/j.rpor.2020.08.006_bib0125","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) As part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J Clin Oncol"},{"issue":"February (2)","key":"10.1016\/j.rpor.2020.08.006_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"June (2)","key":"10.1016\/j.rpor.2020.08.006_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3857\/roj.2019.00150","article-title":"Preliminary results of entire pleural intensity-modulated radiotherapy in a neoadjuvant setting for resectable malignant mesothelioma","volume":"37","author":"Hong","year":"2019","journal-title":"Radiat Oncol J"},{"issue":"5","key":"10.1016\/j.rpor.2020.08.006_bib0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): Preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol"},{"issue":"June (18_suppl)","key":"10.1016\/j.rpor.2020.08.006_bib0145","article-title":"Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial","volume":"35","author":"Scherpereel","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.rpor.2020.08.006_bib0150","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jtho.2018.05.038","article-title":"Programmed death 1 blockade with nivolumab in patients with recurrent malignant pleural mesothelioma","volume":"13","author":"Quispel-Janssen","year":"2018","journal-title":"J Thorac Oncol"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T09:16:11Z","timestamp":1613639771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136720301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1507136720301152"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2020.08.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.13.20087189","asserted-by":"object"}]},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimodality treatment in malignant pleural mesothelioma \u2013 Ordeal or real deal?","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}